KRABEVA
Biocon shares gains on cancer drug launchA biosimilar is a near copy of an original complex biologic drug.
Biocon introduces oncologic biosimilar KRABEVA in IndiaThe biosimilar product will be used for the treatment of patients with metastatic colorectal cancer and other types of lung, kidney, cervic...
- Load More